SCHEMBL2017650

SCHEMBL2017650

[C]#Cc1cccc(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752536 0.81 APP (0.35)
SCHEMBL4968126 0.79 CYP3A4 (0.58)
SCHEMBL8710625 0.77
SCHEMBL107461 0.75
SCHEMBL9611202 0.75 FFAR1 (0.59)
SCHEMBL14154506 0.75
SCHEMBL514947 0.75
SCHEMBL29907774 0.75
SCHEMBL71478 0.75
SCHEMBL29517490 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2736514-B1 ALKYNYL SUBSTITUTED PYRIMIDINYL-PYRROLES ACTIVE AS KINASES INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2017-10-18 EP disclosed
EP-3045457-A1 SUBSTITUTED PYRIMIDINYLPYRROLOPYRIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2016-07-20 EP disclosed
EP-2443117-B1 SUBSTITUTED PYRIMIDINYLPYRROLOPYRIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2016-03-23 EP disclosed
US-8969366-B2 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-03-03 US disclosed
US-8912200-B2 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2014-12-16 US disclosed
US-20140194406-A1 ALKYNYL SUBSTITUTED PYRIMIDINYL-PYRROLES ACTIVE AS KINASES INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2014-07-10 US disclosed
EP-2736514-A1 ALKYNYL SUBSTITUTED PYRIMIDINYL-PYRROLES ACTIVE AS KINASES INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2014-06-04 EP disclosed
US-8703961-B2 Thiazole derivatives for the treatment of diseases such as cancer MERCK PATENT GMBH (DE) 2014-04-22 US disclosed
CN-103724627-A Synthesis of novel aminophenylacetenyl-terminated polysilazane UNIV EAST CHINA SCIENCE & TECH 2014-04-16 CN disclosed
US-20130345245-A1 SUBSTITUTED PYRIMIDINYLPYRROLOPYRIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-12-26 US disclosed
WO-2011072779-A1 THIAZOLE DERIVATIVES FOR TREATING DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2011-06-23 WO disclosed
CN-101952287-A Kinases inhibitor and application thereof MERCK SERONO SA 2011-01-19 CN disclosed
WO-2010145998-A1 SUBSTITUTED PYRIMIDINYLPYRROLOPYRIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-12-23 WO disclosed
EP-2028180-A1 Novel aminopyridine derivatives as mGluR5 antagonists ADDEX Pharma S.A. (CH) 2009-02-25 EP disclosed
EP-1603877-B1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS ADDEX PHARMA SA (CH) 2008-11-26 EP disclosed
US-20080004316-A1 Novel aminopyridine derivatives as mGluR5 antagonists ADDEX PHARMACEUTICALS SA (CH) 2008-01-03 US disclosed
US-7205411-B2 Aminopyridine derivatives as mGluR5 antagonists ADDEX PHARMACEUTICALS SA (CH) 2007-04-17 US disclosed
US-20060030601-A1 Novel aminopyridine derivatives as mGluR5 antagonists ADDEX PHARMACEUTICALS SA (CH) 2006-02-09 US disclosed
EP-1603877-A1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS Addex Pharmaceuticals SA (CH) 2005-12-14 EP disclosed
WO-2004078728-A1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS ADDEX PHARMACEUTICALS SA (CH) 2004-09-16 WO disclosed